Mechanisms of podocyte injury and implications for diabetic nephropathy

被引:97
|
作者
Barutta, Federica [1 ]
Bellini, Stefania [1 ]
Gruden, Gabriella [1 ]
机构
[1] Univ Turin, Dept Med Sci, Turin, Italy
关键词
GLYCATION END-PRODUCTS; CANNABINOID RECEPTOR 1; SHARED TRANSCRIPTIONAL NETWORKS; NLRP3 INFLAMMASOME ACTIVATION; GLOMERULAR-FILTRATION-RATE; GLUCAGON-LIKE PEPTIDE-1; KIDNEY-DISEASE; MITOCHONDRIAL DYSFUNCTION; HIGH-GLUCOSE; NEPHROTIC SYNDROME;
D O I
10.1042/CS20210625
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Albuminuria is the hallmark of both primary and secondary proteinuric glomerulopathies, including focal segmental glomerulosclerosis (FSGS), obesity-related nephropathy, and diabetic nephropathy (DN). Moreover, albuminuria is an important feature of all chronic kidney diseases (CKDs). Podocytes play a key role in maintaining the permselectivity of the glomerular filtration barrier (GFB) and injury of the podocyte, leading to foot process (FP) effacement and podocyte loss, the unifying underlying mechanism of proteinuric glomerulopathies. The metabolic insult of hyperglycemia is of paramount importance in the pathogenesis of DN, while insults leading to podocyte damage are poorly defined in other proteinuric glomerulopathies. However, shared mechanisms of podocyte damage have been identified. Herein, we will review the role of haemodynamic and oxidative stress, inflammation, lipotoxicity, endocannabinoid (EC) hypertone, and both mitochondrial and autophagic dysfunction in the pathogenesis of the podocyte damage, focussing particularly on their role in the pathogenesis of DN. Gaining a better insight into the mechanisms of podocyte injury may provide novel targets for treatment. Moreover, novel strategies for boosting podocyte repair may open the way to podocyte regenerative medicine. The kidneys filter approximately 180 l of fluids everyday; however, there is no loss of proteins into urine as the glomerular filtration barrier (GFB) retains 99.99% of plasma proteins. Alterations in the GFB result in the development of proteinuria, ranging from albuminuria to massive nephrotic syndrome. Albuminuria is the hallmark of both primary and secondary proteinuric glomerulopathies, including focal segmental glomerulosclerosis (FSGS), diabetic nephropathy (DN), obesity-related nephropathy, and an important feature of chronic kidney diseases (CKDs). In addition, in patients with CKD, albuminuria is a predictor of progression towards end-stage renal disease (ESRD) and is associated with an increased risk of cardiovascular diseases. Glomerular podocytes are a component of the GFB and podocyte injury is the main cause of albuminuria development. Herein, we will describe patterns of podocyte damage and review underlying mechanisms, focussing particularly on DN.
引用
收藏
页码:493 / 520
页数:28
相关论文
共 50 条
  • [21] PPBP as a marker of diabetic nephropathy podocyte injury via Bioinformatics Analysis
    Zhang, Fengxia
    Jiang, Nan
    Gao, Yan
    Fan, Zuyan
    Li, Quhuan
    Ke, Guibao
    Li, Bohou
    Wu, Qiong
    Xu, Ruiquan
    Liu, Shuangxin
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 577 : 165 - 172
  • [22] Connexin 43-autophagy loop in the podocyte injury of diabetic nephropathy
    Ji, Jialing
    Zhao, Yajie
    Na, Chen
    Yang, Min
    Zhu, Xianyi
    Shi, Huimin
    Gan, Weihua
    Zhang, Aiqing
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2019, 44 (05) : 1781 - 1788
  • [23] Defensive role of mitochondrial fusion against podocyte injury in diabetic nephropathy
    Koh, E.
    Kim, M.
    C, R. K.
    Lee, S.
    Kim, E.
    Lee, W.
    Lee, I. -K.
    Jang, H.
    Park, J. -Y.
    Park, I. -S.
    Lee, K. -U.
    DIABETOLOGIA, 2009, 52 : S410 - S410
  • [24] Podocyte injury of diabetic nephropathy: Novel mechanism discovery and therapeutic prospects
    Li, Xiandeng
    Zhang, Ying
    Xing, Xiaodong
    Li, Mi
    Liu, Yan
    Xu, Ajing
    Zhang, Jian
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 168
  • [25] Podocyte injury promotes progressive nephropathy in Zucker diabetic fatty rats
    Hoshi, S
    Shu, YJ
    Yoshida, F
    Inagaki, T
    Sonoda, J
    Watanabe, T
    Nomoto, K
    Nagata, M
    LABORATORY INVESTIGATION, 2002, 82 (01) : 25 - 35
  • [26] MiRNA-337 leads to podocyte injury in mice with diabetic nephropathy
    Zhao, S-M
    Zhang, T.
    Qiu, Q.
    Xu, C.
    Ma, L-J
    Liu, J.
    Wang, Z.
    Li, Y-C
    Huang, J.
    Zhang, M.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (19) : 8485 - 8492
  • [27] Targeting endothelin signaling in podocyte injury and diabetic nephropathy-diabetic kidney disease
    Empitu, Maulana Antiyan
    Rinastiti, Pranindya
    Kadariswantiningsih, Ika Nindya
    JOURNAL OF NEPHROLOGY, 2025, 38 (01) : 49 - 60
  • [28] Histone deacetylase 4 selectively contributes to podocyte injury in diabetic nephropathy
    Wang, Xiaojie
    Liu, Jiang
    Zhen, Junhui
    Zhang, Chun
    Wan, Qiang
    Liu, Guangyi
    Wei, Xinbing
    Zhang, Yan
    Wang, Ziying
    Han, Huirong
    Xu, Huiyan
    Bao, Chanchan
    Song, Zhenyu
    Zhang, Xiumei
    Li, Ningjun
    Yi, Fan
    KIDNEY INTERNATIONAL, 2014, 86 (04) : 712 - 725
  • [29] BMP4 regulates podocyte injury in the diabetic nephropathy.
    Tominaga, T.
    Abe, H.
    Nagai, K.
    Mima, A.
    Kishi, S.
    Ueda, O.
    Jishage, K-I
    Fukushima, N.
    Doi, T.
    MOLECULAR BIOLOGY OF THE CELL, 2012, 23
  • [30] Ferroptosis in diabetic nephropathy: Mechanisms and therapeutic implications
    Mengstie, Misganaw Asmamaw
    Seid, Mohammed Abdu
    Gebeyehu, Natnael Atnafu
    Adella, Getachew Asmare
    Kassie, Gizchew Ambaw
    Bayih, Wubet Alebachew
    Gesese, Molalegn Mesele
    Anley, Denekew Tenaw
    Feleke, Sefineh Fenta
    Zemene, Melkamu Aderajew
    Dessie, Anteneh Mengist
    Solomon, Yenealem
    Bantie, Berihun
    Dejenie, Tadesse Asmamaw
    Teshome, Assefa Agegnehu
    Abebe, Endeshaw Chekol
    METABOLISM OPEN, 2023, 18